2024-02-15 13:24:48
The drug Prolia o Xgeva (whose active ingredient is denosumab) continues to be a drug that causes more harm than benefit. The prestigious French magazine Prescribehas included it again in 2024 on the list of medicines not to be used.
This is what they say from the Sano y Salvo blog: Medications to avoid for safer care: the Prescrire blacklist 2024.
This publication is the most prominent in the world on pharmacovigilancein counting the damage caused by many medications that are on the market despite their almost zero need, their low effectiveness and multiple adverse effects.
And it turns out that it updated, at the end of 2023, the list of treatments to avoid to offer quality care and not cause disproportionate damage to the patients.
Specifically, Prolia is prescribed for osteoporosis, the loss of bone matter that sometimes appears with age. But precisely its damage is related to what it is trying to “cure”: back, muscle and bone pain, osteonecrosismultiple fractures after its interruption, and also immune alterations, endocarditis and other infections.
This is stated by Prescrire, who also explains that denosumab 120 mg is authorized in several situations, including patients with bone metastases from tumors solids.
With this diagnosisthe drug is just one of several options available, but its damage they do not clearly outweigh its benefits.
And, as we have published on different occasions, Prolia is a bone drug that can cause bone breaks. The treatment causes problems even when it is stopped because the withdrawal of the medication produces a negative rebound effect.
Wow, it is a very complete product. Furthermore, there are alternatives. I leave you a link to a post on this blog where I explain some of the natural alternatives to medicine.
If you have suffered damage Contact us to analyze your case.
Related
#Prolia #bonebreaking #bone #drug #shouldnt